AIP
IBBQ icon

Ahrens Investment Partners’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

Ahrens Investment Partners’s Portfolio IBBQ Stock Details IBBQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-400
Closed -$8K – 1009
2022
Q1 		$8K Hold
400
– – ﹤0.01% 771
2021
Q4 		$9K Buy
+400
New +$9.75K ﹤0.01% 768

Other funds holding IBBQ

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BBP
Banco BTG Pactual Rio De Janeiro, Brazil $1.14B AUM 41.39% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
CIAS
Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return
CAL
Capital Analysts LLC Fort Washington, Pennsylvania $3.81B AUM 15.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ahrens Investment Partners's IBBQ Position: Q2 2022 in Review

Ahrens Investment Partners sold out of Invesco NASDAQ Biotechnology ETF (IBBQ) in Q2 2022, closing a stake of 400 shares — an estimated $8K sold.

Ahrens Investment Partners first reported a position in IBBQ in Q4 2021 and held it in 2 quarters. The position peaked at $9K in Q4 2021. 9 funds tracked by Wall St. Rank hold IBBQ as of Q2 2022.

  • Ahrens Investment Partners reported no remaining Invesco NASDAQ Biotechnology ETF position as of Q2 2022 after selling out during the quarter.
  • Ahrens Investment Partners sold 400 Invesco NASDAQ Biotechnology ETF shares in Q2 2022, an estimated $8K.
  • Ahrens Investment Partners first reported a position in Invesco NASDAQ Biotechnology ETF in Q4 2021 and held it in 2 quarters.
  • Ahrens Investment Partners's Invesco NASDAQ Biotechnology ETF position peaked at $9K in Q4 2021.
  • 9 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q2 2022.

Based on Ahrens Investment Partners's 13F filing for Q2 2022, filed 2 Aug 2022.